The Whole Genome And Exome Sequencing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Whole Genome And Exome Sequencing Market?
The market size for whole genome and exome sequencing has seen considerable expansion in the past few years. The market, which was worth $2.02 billion in 2024, is expected to rise to $2.53 billion in 2025, which implies a compound annual growth rate (CAGR) of 24.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Whole Genome And Exome Sequencing Industry?
The Whole Genome And Exome Sequencing Global Market is predicted to reach a value of $6.14 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 24.9%.
Download Your Free Sample of the 2025 Whole Genome And Exome Sequencing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Whole Genome And Exome Sequencing Market?
The key drivers in the whole genome and exome sequencing market are:
• Increasing initiatives in population genomics
• Rising demand for precision medicine and advancements in single-cell sequencing
• Expansion of non-invasive prenatal testing (NIPT) and its application in rare disease research
• Expanded clinical adoption, rapid advancements in sequencing technologies, and integration of AI and Machine learning.
Global Market Segmentation: Identifying Major Whole Genome And Exome Sequencing Industry Segments
The whole genome and exome sequencing market covered in this report is segmented –
1) By Product Type: Kits, Instruments
2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)
3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications
4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users
Pre-order the 2025 Whole Genome And Exome Sequencing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Whole Genome And Exome Sequencing Market?
The key trends in the whole genome and exome sequencing market are:
• The growing adoption of whole genome and exome sequencing in clinical applications is a key emerging trend.
• Rapid technological improvements in sequencing methodologies are significantly influencing the market.
• There is an increasing trend towards population-scale genomic studies using these sequencing techniques.
• Integration of AI and ML into whole genome and exome sequencing procedures, particularly in oncology, is another significant trend.
Who Are the Top Competitors & Leading Players in the Whole Genome And Exome Sequencing Market?
Major companies in the whole genome and exome sequencing market are:
• Siemens AG
• Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Cytiva (Danaher Corporation)
• Laboratory Corporation of America Holdings (Labcorp)
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Illumina Inc.
• Canon Medical Systems Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN N.V
• Neusoft Corporation
• BGI Genomics
• Mirion Technologies (Capintec) Inc.
• Novogene Co.
• Oxford Nanopore Technologies Inc.
• LANDAUER
• Pacific Biosciences of California Inc.
• Digirad Corporation
• Berthold Technologies GmbH & Co.KG
• GENEWIZ Inc.
• Incom Inc.
• Lucerno Dynamics LLC
• Absolute Imaging Inc.
• Mediso Ltd.
• Ashby Gorman Baker Ltd.
• DDD-Diagnostic AS
• SurgicEye GmbH
• CMR Naviscan
Regional Dominance: Which Area Leads the Global Whole Genome And Exome Sequencing Market?
North America was the largest region in the whole genome and exome sequencing market in 2024
